FDA NDC Directory · JSON-LD · Markdown

Pivekimab sunirine drug product (DP)

NDC 43624-039 · DRUG FOR FURTHER PROCESSING · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerBSP Pharmaceuticals S.p.A.
Marketing categoryDRUG FOR FURTHER PROCESSING
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Active ingredientsPIVEKIMAB SUNIRINE (2 mg/mL)
Marketing started20260529
Package count1

External sources

Source: openFDA. Public-domain (CC0).